147 related articles for article (PubMed ID: 23311370)
1. Mathematical analysis and simulations involving chemotherapy and surgery on large human tumours under a suitable cell-kill functional response.
Rodrigues DS; de Arruda Mancera PF
Math Biosci Eng; 2013 Feb; 10(1):221-34. PubMed ID: 23311370
[TBL] [Abstract][Full Text] [Related]
2. X chemotherapy, myth and realities.
Thomas M; Pavithran K
J Indian Med Assoc; 2005 Sep; 103(9):489-90, 492, 494. PubMed ID: 16493871
[TBL] [Abstract][Full Text] [Related]
3. Mathematical modeling of ovarian cancer treatments: sequencing of surgery and chemotherapy.
Kohandel M; Sivaloganathan S; Oza A
J Theor Biol; 2006 Sep; 242(1):62-8. PubMed ID: 16580022
[TBL] [Abstract][Full Text] [Related]
4. [Evolution of methods of chemotherapy in solid tumors in the children].
Olive D
Arch Fr Pediatr; 1976; 33(6):607-20. PubMed ID: 949222
[TBL] [Abstract][Full Text] [Related]
5. On optimal and suboptimal treatment strategies for a mathematical model of leukemia.
Fimmel E; Semenov YS; Bratus AS
Math Biosci Eng; 2013 Feb; 10(1):151-65. PubMed ID: 23311366
[TBL] [Abstract][Full Text] [Related]
6. Optimal controls for a model with pharmacokinetics maximizing bone marrow in cancer chemotherapy.
Ledzewicz U; Schättler H
Math Biosci; 2007 Apr; 206(2):320-42. PubMed ID: 16197967
[TBL] [Abstract][Full Text] [Related]
7. Gompertz model with delays and treatment: mathematical analysis.
Bodnar M; Piotrowska MJ; Foryś U
Math Biosci Eng; 2013 Jun; 10(3):551-63. PubMed ID: 23906135
[TBL] [Abstract][Full Text] [Related]
8. Model for tumour growth with treatment by continuous and pulsed chemotherapy.
Borges FS; Iarosz KC; Ren HP; Batista AM; Baptista MS; Viana RL; Lopes SR; Grebogi C
Biosystems; 2014 Feb; 116():43-8. PubMed ID: 24333154
[TBL] [Abstract][Full Text] [Related]
9. Optimal robust control of drug delivery in cancer chemotherapy: a comparison between three control approaches.
Moradi H; Vossoughi G; Salarieh H
Comput Methods Programs Biomed; 2013 Oct; 112(1):69-83. PubMed ID: 23891423
[TBL] [Abstract][Full Text] [Related]
10. Optimizing drug regimens in cancer chemotherapy by an efficacy-toxicity mathematical model.
Iliadis A; Barbolosi D
Comput Biomed Res; 2000 Jun; 33(3):211-26. PubMed ID: 10860586
[TBL] [Abstract][Full Text] [Related]
11. Adaptive robust control of cancer chemotherapy in the presence of parametric uncertainties: a comparison between three hypotheses.
Moradi H; Sharifi M; Vossoughi G
Comput Biol Med; 2015 Jan; 56():145-57. PubMed ID: 25464356
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy in epithelial ovarian cancer.
Pignata S; Cannella L; Leopardo D; Pisano C; Bruni GS; Facchini G
Cancer Lett; 2011 Apr; 303(2):73-83. PubMed ID: 21353386
[TBL] [Abstract][Full Text] [Related]
13. [Kinetics of breast neoplasms].
Surbone A; Norton L
Minerva Med; 1994; 85(1-2):7-16. PubMed ID: 8152580
[TBL] [Abstract][Full Text] [Related]
14. Ultrasound assistant chemotherapy may be a novel modality for solid tumors.
Pan H; Ma X; Li M; Chen J; Jiang H
Med Hypotheses; 2009 Oct; 73(4):526-7. PubMed ID: 19573996
[TBL] [Abstract][Full Text] [Related]
15. Mathematical modelling for the assessment of the effect of drug application delays in metronomic chemotherapy of cancer due to physiological constraints.
Mukherjee A; Majumder D
Biosystems; 2008 Jan; 91(1):108-16. PubMed ID: 17889991
[TBL] [Abstract][Full Text] [Related]
16. Mathematical modeling of cancer progression and response to chemotherapy.
Sanga S; Sinek JP; Frieboes HB; Ferrari M; Fruehauf JP; Cristini V
Expert Rev Anticancer Ther; 2006 Oct; 6(10):1361-76. PubMed ID: 17069522
[TBL] [Abstract][Full Text] [Related]
17. [Dosage regimen optimization in cancer chemotherapy using a mathematical model].
Barbolosi D; Freyer G; Ciccolini J; Iliadis A
Bull Cancer; 2003 Feb; 90(2):167-75. PubMed ID: 12660135
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy for tumors: an analysis of the dynamics and a study of quadratic and linear optimal controls.
de Pillis LG; Gu W; Fister KR; Head T; Maples K; Murugan A; Neal T; Yoshida K
Math Biosci; 2007 Sep; 209(1):292-315. PubMed ID: 17306310
[TBL] [Abstract][Full Text] [Related]
19. Therapy burden, drug resistance, and optimal treatment regimen for cancer chemotherapy.
Boldrini JL; Costa MI
IMA J Math Appl Med Biol; 2000 Mar; 17(1):33-51. PubMed ID: 10757031
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy may be delivered based on an integrated view of tumour dynamics.
Ribba B; You B; Tod M; Girard P; Tranchand B; Trillet-Lenoir V; Freyer G
IET Syst Biol; 2009 May; 3(3):180-90. PubMed ID: 19449978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]